About AMA Opioid Task Force
In 2015, the American Medical Association convened more than 25 national, state, specialty and other health care associations to develop industry-wide recommendations for physicians to help end the nation’s opioid epidemic. The Task Force continues its work to urge physicians to demonstrate leadership to help their patients as well as urging policymakers to take action and standup to health insurance companies and others who continue to erect and support barriers to evidence-based care for patients with pain and patients with a substance use disorder.
Recommendations for Physicians (2015)
These recommendations guide the nation’s medical societies and physicians’ efforts on a daily basis. As demonstrated in the 2019 Task Force progress report, physicians have taken significant steps across the board on each of the recommendations below.
- Support physicians’ use of effective PDMPs.
- Enhance education on effective, evidence-based prescribing and treatment.
- Support access to comprehensive, affordable, compassionate treatment.
- Put an end to stigma.
- Expand access to naloxone in the community and through co-prescribing.
- Encourage safe storage and disposal of prescription medication.
Recommendations for Policymakers (2019)
In light of the worsening and changing epidemic, the Task Force issued new recommendations urging policymakers’ action to remove barriers for evidence-based care for patients with pain and patients with opioid use disorder.
- Remove inappropriate administrative burdens or barriers that delay or deny care for FDA-approved medications used to help treat opioid use disorder (OUD).
- Support assessment, referral, and treatment for co-occurring mental disorders as well as enforce meaningful oversight and enforcement of state and federal mental health and substance use disorder parity laws.
- Remove administrative and other barriers to comprehensive, multimodal, multidisciplinary pain care and rehabilitation programs.
- Support maternal and child health by increasing access to evidence-based treatment, preserving families, and ensuring that policies are non-punitive.
- Support reforms in the civil and criminal justice system that help ensure access to high-quality, evidence-based care for opioid use disorder, including MAT
Advocacy and Action to End the Opioid Epidemic by the AMA Opioid Task Force
By Patrice A. Harris, MD, MA, Chair, AMA Opioid Task Force; Bobby Mukkamala, MD, Chair AMA Pain Care Task Force
AMA Education Hub: Opioid and Pain Management: Guidelines, Research and Treatments
Fulfill your state-mandated CME credits while enhancing your knowledge of opioid and non-opioid pain management, safe opioid prescribing and substance use treatment. Learn now. CME 44.25 Total Credits
AMA-Manatt National Roadmap on State-Level Efforts to End the Opioid Epidemic
Leading-edge Practices and Next Steps
ACOG District II Opioid Use Disorder in Pregnancy Bundle – Part 1
Readiness, Recognition and Prevention
ACOG District II Opioid Use Disorder (OUD) in Pregnancy Bundle – Part 2
Response & Reporting
Pain Management Program 2018 Update
This program will cover topics in Pain Management including: Pain Assessment, Opioid Titration, Understanding and Managing Adverse Effects of Opioid Analgesics, and Achieving Balance: Under or Overtreatment of Pain in Oncology.
Joint Public Correctional Policy Statement on the Treatment of Opioid Use Disorders for Justice Involved Individuals
A Joint Statement by the American Correctional Association (ACA) and ASAM support the use of evidence-based practices for the treatment of opioid use disorders for individuals within the criminal justice system.
Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids
Given the complex needs of pregnant and postpartum women and their children, and the number of systems they encounter during critically important periods in their lives, ASAM provides policy recommendations on substance use, misuse, and SUDs during and following pregnancy.